A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation

Simon, 2003, Small cell lung cancer, Chest, 123, 259S, 10.1378/chest.123.1_suppl.259S Stupp, 2004, Small cell lung cancer: state of the art and future perspectives, Lung Cancer, 45, 105, 10.1016/j.lungcan.2003.12.006 Rigas, 2005, Current perspectives on treatment strategies for locally advanced, unresectable stage III non-small cell lung cancer, Lung Cancer, 50S2, S17, 10.1016/S0169-5002(05)81569-7 Thompson, 1995, Apoptosis in the pathogenesis and treatment of disease, Science, 267, 1456, 10.1126/science.7878464 Meier, 2000, Apoptosis in development, Nature, 407, 796, 10.1038/35037734 Maundrell, 1997, Bcl-2 undergoes phosphorylation by c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1, J Biol Chem, 272, 25238, 10.1074/jbc.272.40.25238 Wada, 2004, Mitogen-activated protein kinases in apoptosis regulation, Oncogene, 23, 2838, 10.1038/sj.onc.1207556 Guyton, 1996, Activation of mitogen-activated protein kinase by H2O2. Role in cell survival following oxidant injury, J Biol Chem, 271, 4138, 10.1074/jbc.271.8.4138 Yang, 1996, Molecular thanatopsis: a discourse on the BCL2 family and cell death, Blood, 88, 386, 10.1182/blood.V88.2.386.bloodjournal882386 White, 1996, Life, death, and the pursuit of apoptosis, Genes Dev, 10, 1, 10.1101/gad.10.1.1 Antonsson, 2000, The Bcl-2 protein family, Exp Cell Res, 256, 50, 10.1006/excr.2000.4839 Adams, 2007, The Bcl-2 apoptotic switch in cancer development and therapy, Oncogene, 26, 1324, 10.1038/sj.onc.1210220 Reed, 1994, Bcl-2 and the regulation of programmed cell death, J Cell Biol, 124, 1, 10.1083/jcb.124.1.1 Du, 2005, Characterization of vinblastine-induced Bcl-xL and Bcl-2 phosphorylation: evidence for a novel protein kinase and a coordinated phosphorylation/dephosphorylation cycle associated with apoptosis induction, Oncogene, 24, 107, 10.1038/sj.onc.1208189 Kharbanda, 2000, Translocation of SAPK/JNK to mitochondria and interaction with Bcl-x(L) in response to DNA damage, J Biol Chem, 275, 322, 10.1074/jbc.275.1.322 Poruchynsky, 1998, Bcl-xL is phosphorylated in malignant cells following microtubule disruption, Cancer Res, 58, 3331 Basu, 2003, Identification of a novel Bcl-xL phosphorylation site regulating the sensitivity of taxol- or 2-methoxyestradiol-induced apoptosis, FEBS Lett, 538, 41, 10.1016/S0014-5793(03)00131-5 Barr, 2001, The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs), Int J Biochem Cell Biol, 33, 1047, 10.1016/S1357-2725(01)00093-0 Jin, 2006, Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of surviving, Biochem Pharmacol, 72, 1228, 10.1016/j.bcp.2006.07.026 Gupta, 1995, Transcription factor ATF2 regulation by the JNK signal transduction pathway, Science, 267, 389, 10.1126/science.7824938 Seo, 2007, Sulindac-derived reactive oxygen species induce apoptosis of human multiple myeloma cells via p38 mitogen activated protein kinase-induced mitochondrial dysfunction, Apoptosis, 12, 195, 10.1007/s10495-006-0527-5 Woo, 2002, Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells, Int J Oncol, 21, 57 Hundley, 2006, Nitric oxide-donating aspirin inhibits colon cancer cell growth via mitogen-activated protein kinase activation, J Pharmacol Exp Ther, 316, 25, 10.1124/jpet.105.091363 Chen, 2006, Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors, Cancer Res, 66, 11416, 10.1158/0008-5472.CAN-06-0409 Czibere, 2005, The nonsteroidal anti-inflammatory drug Exisulind selectively induces apoptosis via JNK in secondary acute myeloid leukemia after myelodysplastic syndrome, Cell Cycle, 4, 812, 10.4161/cc.4.6.1722 Zhuo, 1993, Expression, purification, crystallization, and biochemical characterization of a recombinant protein phosphatase, J Biol Chem, 268, 17754, 10.1016/S0021-9258(17)46769-X Zamzami, 1995, Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo, J Exp Med, 181, 1661, 10.1084/jem.181.5.1661 González-García, 1994, Bcl-XL is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria, Development, 120, 3033, 10.1242/dev.120.10.3033 Brozovic, 2004, Long-term activation of SAPK/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance, Int J Cancer, 112, 974, 10.1002/ijc.20522 Teraishi, 2005, Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cells, FEBS Lett, 579, 6681, 10.1016/j.febslet.2005.10.064 Uzgare, 2003, Differential expression and/or activation of P38MAPK, erk1/2, and jnk during the initiation and progression of prostate cancer, Prostate, 55, 128, 10.1002/pros.10212 Wang, 2000, Downregulation of mitogen-activated protein kinases in human colon cancers, Anticancer Res, 20, 75 Vicent, 2004, Mitogen-activated protein kinase phosphatase-1 is overexpressed in non-small cell lung cancer and is an independent predictor of outcome in patients, Clin Cancer Res, 10, 3639, 10.1158/1078-0432.CCR-03-0771 Benhar, 2001, Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress, Mol Cell Biol, 21, 6913, 10.1128/MCB.21.20.6913-6926.2001 Jin, 2006, Up-regulation of Bak and Bim via JNK downstream pathway in the response to nitric oxide in human glioblastoma cells, J Cell Physiol, 206, 477, 10.1002/jcp.20488 Ueda, 2002, Redox control of cell death, Antioxid Redox Signal, 4, 405, 10.1089/15230860260196209 Chen, 1996, Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis, J Biol Chem, 271, 631, 10.1074/jbc.271.2.631 Butterfield, 1997, c-Jun NH2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation, J Biol Chem, 272, 10110, 10.1074/jbc.272.15.10110 Le-Niculescu, 1999, Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death, Mol Cell Biol, 19, 751, 10.1128/MCB.19.1.751 Fan, 2000, Vinblastine-induced phosphorylation of Bcl-2 and Bcl-XL is mediated by JNK and occurs in parallel with inactivation of the Raf-1/MEK/ERK cascade, J Biol Chem, 275, 29980, 10.1074/jbc.M003776200 Srivastava, 1999, Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis, Proc Natl Acad Sci USA, 96, 3775, 10.1073/pnas.96.7.3775